ASP
VERA icon

Adams Street Partners’s Vera Therapeutics VERA Stock Holding History

Adams Street Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,114
Closed -$474K – 9
2024
Q2 		$474K Buy
+13,114
New +$520K 0.2% 9

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adams Street Partners's VERA Position: Q3 2024 in Review

Adams Street Partners sold out of Vera Therapeutics (VERA) in Q3 2024, closing a stake of 13,114 shares — an estimated $474K sold.

Adams Street Partners first reported a position in VERA in Q2 2024 and held it in 1 quarter. The position peaked at $474K in Q2 2024. 173 funds tracked by Wall St. Rank hold VERA as of Q3 2024.

  • Adams Street Partners reported no remaining Vera Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Adams Street Partners sold 13,114 Vera Therapeutics shares in Q3 2024, an estimated $474K.
  • Adams Street Partners first reported a position in Vera Therapeutics in Q2 2024 and held it in 1 quarter.
  • Adams Street Partners's Vera Therapeutics position peaked at $474K in Q2 2024.
  • 173 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2024.

Based on Adams Street Partners's 13F filing for Q3 2024, filed 14 Nov 2024.